Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

NCT03806933 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
241
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merz Aesthetics GmbH

Collaborators